News coverage about Varian Medical Systems (NYSE:VAR) has trended somewhat positive on Tuesday, Accern reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Varian Medical Systems earned a daily sentiment score of 0.02 on Accern’s scale. Accern also gave news coverage about the medical equipment provider an impact score of 48.4275120306308 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Here are some of the news headlines that may have impacted Accern’s rankings:
- Varian Medical Systems, Inc. (VAR) EVP Kolleen T. Kennedy Sells 2,021 Shares (americanbankingnews.com)
- Notable Stocks Buzz: Concho Resources Inc., (NYSE: CXO), Varian Medical Systems, Inc., (NYSE: VAR), Vicon … – Stocks In The News (press release) (tradingnewsnow.com)
- Legal Departments of the Year, Litigation, Large Companies: Varian Medical Systems – Law.com (law.com)
- Legal Departments of the Year, In-House Impact Award: Keith Askoff, Varian Medical Systems – Law.com (law.com)
Varian Medical Systems (NYSE:VAR) traded up $0.69 during mid-day trading on Tuesday, reaching $108.24. 639,700 shares of the company traded hands, compared to its average volume of 876,119. The firm has a market capitalization of $9,873.19, a price-to-earnings ratio of 28.53, a PEG ratio of 3.16 and a beta of 0.65. The company has a current ratio of 1.41, a quick ratio of 1.13 and a debt-to-equity ratio of 0.18. Varian Medical Systems has a 52 week low of $76.94 and a 52 week high of $108.78.
Varian Medical Systems (NYSE:VAR) last released its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The company had revenue of $739.00 million during the quarter, compared to analysts’ expectations of $741.69 million. During the same period last year, the firm posted $1.03 earnings per share. Varian Medical Systems’s revenue was down 1.1% on a year-over-year basis. research analysts predict that Varian Medical Systems will post 4.26 EPS for the current year.
A number of analysts have recently issued reports on the company. Zacks Investment Research cut Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. Robert W. Baird restated a “hold” rating and set a $99.00 target price on shares of Varian Medical Systems in a research report on Monday, August 28th. Royal Bank Of Canada reiterated a “hold” rating and issued a $100.00 price objective on shares of Varian Medical Systems in a research report on Friday, September 1st. BidaskClub lowered shares of Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Finally, Citigroup Inc. raised their price objective on shares of Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a report on Monday, October 30th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the stock. Varian Medical Systems currently has a consensus rating of “Hold” and a consensus target price of $97.83.
In other Varian Medical Systems news, EVP Kolleen T. Kennedy sold 931 shares of the firm’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $105.00, for a total value of $97,755.00. Following the sale, the executive vice president now directly owns 27,531 shares in the company, valued at $2,890,755. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Kolleen T. Kennedy sold 2,021 shares of Varian Medical Systems stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $107.36, for a total transaction of $216,974.56. Following the sale, the executive vice president now owns 27,595 shares in the company, valued at $2,962,599.20. The disclosure for this sale can be found here. Over the last three months, insiders sold 42,761 shares of company stock worth $4,447,864. 0.91% of the stock is owned by corporate insiders.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.
Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.